Cytokinetics officer proposes $1.03M share sale

The listed prior sales run from July 21 through October 6, 2026, with each entry covering 3,500 shares.

Rhea-AI Filing Summary

Cytokinetics, Inc. officer Fady Malik gave notice of a proposed sale of 16,386 common shares, with an aggregate market value of $1,026,582.90 and an approximate sale date of October 20, 2026. The shares to be sold were and will be received through stock-option exercises over the next three months. The notice also lists prior 3,500-share sales as 10b5-1 sales.

Key Figures

Common shares proposed for sale: 16,386 shares Aggregate market value of proposed sale: $1,026,582.90 Common shares outstanding: 139,023,418 shares +1 more

4 metrics

Common shares proposed for sale 16,386 shares Approximate sale date October 20, 2026

Aggregate market value of proposed sale $1,026,582.90 Proposed sale of 16,386 common shares

Common shares outstanding 139,023,418 shares Count shown in the securities information

Shares per listed prior sale 3,500 shares Each listed sale during the past three months

Key Terms

Rule 144, 10b5-1 Sales, Exercise of Stock Options

3 terms

Rule 144 regulatory

"definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 Sales regulatory

"10b5-1 Sales for FADY MALIK"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Exercise of Stock Options financial

"Exercise of Stock Options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CYTK shares does Fady Malik plan to sell?

Officer Fady Malik gave notice of a proposed sale of 16,386 common shares, with an aggregate market value of $1,026,582.90 and an approximate sale date of October 20, 2026.

How will Fady Malik receive the CYTK shares covered by the notice?

The notice says the shares to be sold were and will be received through stock-option exercises over the next three months. It states that the dates of acquisition and payment were and will be the dates of exercise and sale.

What prior CYTK sales by Fady Malik are listed?

The notice lists 3,500-share 10b5-1 sales on October 6, September 22, September 8, August 18, August 4 and July 21, 2026. Their reported aggregate market values, respectively, are $214,829.30, $239,004.85, $264,093.90, $265,381.90, $273,916.65 and $282,058.00.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/20/2026 - 04:26 PM EDT Accepted by SEC EDGAR 10/20/2026 - 04:25 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001551778
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CYTOKINETICS, INCORPORATED
SEC File Number	000-50633
Address of Issuer	350 Oyster Point Blvd. SOUTH SAN FRANCISCO CALIFORNIA 94080
Phone	6506243000
Name of Person for Whose Account the Securities are To Be Sold	FADY MALIK
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	16386	1026582.90	139023418	10/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/20/2026	Exercise of Stock Options	Issuer			16386	10/20/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for FADY MALIK 350 Oyster Point Blvd. SOUTH SAN FRANCISCO CA 94080	Common	10/06/2026	3500	214829.30
10b5-1 Sales for FADY MALIK 350 Oyster Point Blvd. SOUTH SAN FRANCISCO CA 94080	Common	09/22/2026	3500	239004.85
10b5-1 Sales for FADY MALIK 350 Oyster Point Blvd. SOUTH SAN FRANCISCO CA 94080	Common	09/08/2026	3500	264093.90
10b5-1 Sales for FADY MALIK 350 Oyster Point Blvd. SOUTH SAN FRANCISCO CA 94080	Common	08/18/2026	3500	265381.90
10b5-1 Sales for FADY MALIK 350 Oyster Point Blvd. SOUTH SAN FRANCISCO CA 94080	Common	08/04/2026	3500	273916.65
10b5-1 Sales for FADY MALIK 350 Oyster Point Blvd. SOUTH SAN FRANCISCO CA 94080	Common	07/21/2026	3500	282058.00

144: Remarks and Signature

Remarks	The securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	10/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/23/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Fady Malik
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)